A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

NCT06589765 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HRS-7535 tablet
DRUG: dapagliflozin tablet

Sponsor

Shandong Suncadia Medicine Co., Ltd.